Clinical Biostatistics & Data Analysis

Mechanisms of Missingness: MCAR, MAR, MNAR and Why They Matter Mechanisms of Missingness: MCAR, MAR, MNAR and Why They Matter In the realm of clinical research, missing data can significantly undermine the validity and reliability of study findings. Understanding the mechanisms that lead to missingness—namely Missing Completely at Random (MCAR), Missing at Random (MAR), and…

Read More “Mechanisms of Missingness: MCAR, MAR, MNAR and Why They Matter” »

Pre-Specifying Primary Missing Data Methods in Protocol and SAP Pre-Specifying Primary Missing Data Methods in Protocol and SAP In various clinical trials, managing missing data is a critical aspect that significantly impacts the analysis and interpretation of results. Missing data can arise due to various reasons, including participant dropout, protocol deviations, and adverse events. This…

Read More “Pre-Specifying Primary Missing Data Methods in Protocol and SAP” »

Multiple Imputation, Mixed Models and Pattern-Mixture Approaches In the context of clinical trials, data integrity is paramount. Missing data poses significant challenges that can compromise the validity of study findings and lead to incorrect conclusions. The regulatory agencies such as the FDA, EMA, and MHRA emphasize the need for robust statistical methods to handle missing…

Read More “Multiple Imputation, Mixed Models and Pattern-Mixture Approaches” »

Sensitivity Analyses to Test Robustness of Primary Trial Conclusions Sensitivity Analyses to Test Robustness of Primary Trial Conclusions Sensitivity analyses are a crucial methodological component in clinical trials that ensure the reliability of conclusions drawn from study data, especially regarding primary outcomes. Understanding how to implement sensitivity analyses is increasingly vital in clinical research methodologies,…

Read More “Sensitivity Analyses to Test Robustness of Primary Trial Conclusions” »

Handling Missing Baseline, Covariate and Post-Baseline Endpoint Data Handling Missing Baseline, Covariate and Post-Baseline Endpoint Data in Precision Medicine Clinical Trials In clinical trials, the management of missing data is a critical aspect that demands meticulous planning and execution. This article aims to provide a step-by-step tutorial designed for clinical operations, regulatory affairs, and medical…

Read More “Handling Missing Baseline, Covariate and Post-Baseline Endpoint Data” »

Missing Data Challenges in DCT, ePRO and App-Based Trial Designs Missing Data Challenges in DCT, ePRO and App-Based Trial Designs In the rapidly evolving landscape of clinical research, the emergence of decentralized clinical trials (DCT), electronic patient-reported outcomes (ePRO), and app-based trial designs has significantly transformed how data is collected and managed. However, these innovations…

Read More “Missing Data Challenges in DCT, ePRO and App-Based Trial Designs” »

Regulatory Expectations for Missing Data Handling in Pivotal Studies Clinical trials generate vast amounts of data; however, incomplete datasets due to missing data can significantly impact the integrity and outcomes of a study. Regulatory agencies, such as the FDA, EMA, and MHRA, have established guidelines that dictate how missing data should be handled in pivotal…

Read More “Regulatory Expectations for Missing Data Handling in Pivotal Studies” »

Exploratory vs Confirmatory Sensitivity Analyses: Where to Draw the Line Exploratory vs Confirmatory Sensitivity Analyses: Where to Draw the Line In the realm of applied clinical trials, sensitivity analyses serve as pivotal tools that support the robustness and credibility of trial outcomes. As clinical research professionals, particularly in the domains of clinical operations, regulatory affairs,…

Read More “Exploratory vs Confirmatory Sensitivity Analyses: Where to Draw the Line” »

Visualizing Missing Data Patterns for CRAs, Clinicians and Statisticians Visualizing Missing Data Patterns for CRAs, Clinicians and Statisticians In the realm of clinical trials, addressing missing data is crucial to the integrity and interpretability of trial results. Among various methodologies employed to manage missing data, visualization techniques stand out as effective tools for clinical research…

Read More “Visualizing Missing Data Patterns for CRAs, Clinicians and Statisticians” »

Case Studies: Missing Data That Changed Regulatory Outcomes Case Studies: Missing Data That Changed Regulatory Outcomes Missing data is an inevitable challenge in clinical trials, particularly in oncology clinical research, where complex treatment regimens and patient-related factors contribute to incomplete datasets. The consequences of missing data can influence regulatory outcomes significantly. This article provides a…

Read More “Case Studies: Missing Data That Changed Regulatory Outcomes” »